Oxidative stress and ion channels in neurodegenerative diseases

Abstract

Numerous neurodegenerative diseases result from altered ion channel function and mutations. The intracellular redox status can significantly alter the gating characteristics of ion channels. Abundant neurodegenerative diseases associated with oxidative stress have been documented, including Parkinson’s, Alzheimer’s, spinocerebellar ataxia, amyotrophic lateral sclerosis, and Huntington’s disease. Reactive oxygen and nitrogen species compounds trigger posttranslational alterations that target specific sites within the subunits responsible for channel assembly. These alterations include the adjustment of cysteine residues through redox reactions induced by reactive oxygen species (ROS), nitration, and S-nitrosylation assisted by nitric oxide of tyrosine residues through peroxynitrite. Several ion channels have been directly investigated for their functional responses to oxidizing agents and oxidative stress. This review primarily explores the relationship and potential links between oxidative stress and ion channels in neurodegenerative conditions, such as cerebellar ataxias and Parkinson’s disease. The potential correlation between oxidative stress and ion channels could hold promise for developing innovative therapies for common neurodegenerative diseases.

1 Introduction

Reactive oxygen species (ROS) are generated by living organisms as a result of their regular cellular metabolic processes and environmental factors, such as smoking, air pollutants, UV radiation, alcohol consumption, infections, non-steroidal anti-inflammatory drugs (NSAIDs), and inflammation (Valko et al., 2006; Birben et al., 2012). ROS are required in small to moderate amounts for normal cellular functions. However, elevated concentrations induce detrimental alterations to proteins, DNA, and lipids, which hinder cell function (Liguori et al., 2018; Uttara et al., 2009). The lack of antioxidants generates oxidative stress that increases reactive species’ levels (Uttara et al., 2009). Pathological states often result in intracellular oxidative agents overtaking reducing agents, causing redox imbalances and oxidative stress (Simon et al., 2013; Sies et al., 2017). Numerous oxidative stress-related diseases have been reported (Sies et al., 2017; Ramírez et al., 2016), such as neurodegenerative disorders involving Parkinson’s (Henchcliffe and Beal, 2008), Alzheimer’s (Gella and Durany, 2009; Chang et al., 2014), spinocerebellar ataxia (Guevara-García et al., 2012), Huntington’s disease (Browne et al., 1999), and amyotrophic lateral sclerosis (ALS) (Cunha-Oliveira et al., 2020). Several cardiovascular diseases are also linked with oxidative stress, such as hypertension (Griendling et al., 2021), heart failure (Pagan et al., 2022), myocardial ischemia (Kurian et al., 2016), and atherosclerosis (Kattoor et al., 2017). Other pathologies linked to oxidative stress involve obesity (Manna and Jain, 2015), chronic inflammation (Orzechowski et al., 2019), and chronic pain (Kaushik et al., 2020). The literature is rich in presenting compelling evidence of a significant association between neurodegenerative disorders, aging, and oxidative stress (Browne et al., 1999; Gella and Durany, 2009; Uttara et al., 2009; Riverón et al., 2010; Chang et al., 2014; Cunha-Oliveira et al., 2020). Oxidative stress causes neuroinflammation, and mitochondrial dysfunction leads to apoptosis and cell damage that triggers neurodegenerative processes (Figure 1) (Selivanov et al., 2011; Ashok et al., 2022). Several neuroprotective therapies have been developed to combat ROS that damage neurons and cause neurodegenerative disorders (Uttara et al., 2009). The intracellular redox status can significantly alter the gating properties of ion channels (Akbarali, 2014). Indeed, various neurodegenerative diseases result from altered ion channel function and mutations (Li and Lester, 2001).

FIGURE 1

This review is an effort to summarize some of the common modifications in ion channel regulations by ROS in some neurodegenerative disease states.

2 Oxidative stress and ion channels

Oxidative stress passively damages proteins, lipids, and DNA but also directly modulates many molecules in the cell signaling network, such as ion channels. The ion channel is a macromolecular pore in cell membranes that selectively conducts Na+, K+, Ca2+, and Cl–ions. These pores are essential in conducting the ions across cell membranes (Litalien et al., 2011). Different stimuli open ion channels and conduct ions into or out of the cells, including changes in membrane potential, chemical stimuli, or mechanical deformation (Li and Lester, 2001). According to the stimulus they respond to, ion channels can be classified into three superfamilies: voltage-gated (Purves et al., 2001a), ligand-gated (Purves et al., 2001b), or mechanosensitive (Martinac, 2012). Ion channel subtypes are differentiated by their primary structure, distribution, and functional properties (Zheng and Trudeau, 2023). In voltage-gated ion channels, the membrane potential changes, and a specific ion is selectively dissolved; these channels can be categorized into different families based on the ion specificity (Purves et al., 2001a). Neurotransmitters or other ligands can trigger ligand-gated ion channels. There are several subtypes of ligand-gated channels, just like voltage-gated channels. Mechanosensitive ion channels respond to alterations in mechanical forces on the cell membrane (Zheng and Trudeau, 2023). Ion channels play a fundamental role in nerve conduction, neural communication, and muscle contraction, in addition to their conical function of transporting ions across the cell membrane to set membrane potential (Rosendo-Pineda et al., 2020) (Table 1) (Figure 2). Detailed information on recent ion channel types can be found in the excellent textbook by Zheng and Trudeau et al. (Zheng and Trudeau, 2023). There are also multiple reviews on specific types of ion channels (Purves et al., 2001b; Shah and Aizenman, 2014; de Lera Ruiz and Kraus, 2015; Nam et al., 2023a).

FIGURE 2

Posttranslational oxidative modifications of certain proteins, such as ion channels, can result from imbalances in cellular redox state caused by ROS production, ineffective antioxidant defenses, or environmental oxidative stress. (Bogeski and Niemeyer, 2014; Kiselyov and Muallem, 2016). In ion channels and other proteins, cysteine residues are the most vulnerable to oxidation due to their highly reactive thiol groups. It is possible to oxidize thiols into sulfonic acids and sulfonic based on the amount of oxidant present, the redox potential, the amount of charge, and the temperature. Various oxidative modifications can be applied to cysteines, including processes like glutathionylation and nitrosylation. Elevated levels of ROS can lead to the decomposition of amino acids, such as lysine and arginine, into aldehydes or the conversion of methionine residues into sulfoxides and sulfones (Bogeski and Niemeyer, 2014). Reactive nitrogen species (RNS) and ROS have the potential to directly alter ion channels by nitrosylation, nitration, and oxidation of specific amino acid residues. This can eventually affect the signaling pathways that modulate channel function, modifying gene transcription, turnover, proteasomal degradation, and trafficking (Akbarali, 2014). Sensitivity to alterations in the side chains of the amino acid residues that serve as the targets for ROS/RNS is typically associated with the presence of sulfur atoms in (methionine and cysteine), aromatic rings (tryptophan, histidine, and phenylalanine), or hydroxyl groups (tyrosine), (Annunziato et al., 2002; Akbarali, 2014; Miranda et al., 2023). In biological systems, there is a physiological balance between the generation of ROS and their detoxification through antioxidant scavengers, such as glutathione, catalase, and superoxide dismutase. When there is an imbalance, oxidative stress occurs (Gulcin, 2020).

Many types of ion channels are recognized to be modulated by oxidative stress. This modulation can be beneficial in some, while in others, it leads to pathological states (Figure 3) (Akbarali, 2014). For example, alterations in the gating properties and ion selectivity of voltage-gated ion channels may occur. Oxidative stress can also affect ligand-gated ion channels, thereby altering their signaling pathways and sensitivity (Miranda et al., 2023). Another consequence of oxidative stress on regulating intracellular Ca²⁺ levels is its ability to alter the function of Ca²⁺ release channels within the endoplasmic reticulum and Ca²⁺ uptake channels in the cell’s plasma membrane (Santulli et al., 2017). Ion channels might also function as sensors of redox changes, given that various ion channels are closely linked to oxidative stress. Also, ROS-induced damage can be restored through natural protective mechanisms. Consequently, for therapeutic purposes, understanding how these reactants affect ion channel functionality is essential to understanding how oxidative stress-related diseases are triggered.

FIGURE 3

2.1 Regulation of ion channels by antioxidants

Post-translational modifications (PTMs) are significant mechanisms modulating the functions of ion channels. Protein phosphorylation is a classical PTM, and protein kinases regulate many ion channels throughout phosphorylation (Yang et al., 2014). There are different types of PTMs, such as Ubiquitylation, S-glutathionylation, O-glycosylation, etc. Both normal and abnormal states, including oxidative stress, are linked to post-translational modifications (PTMs) mediated by redox processes targeting cysteine residues’ thiol group. Redox-mediated post-translational modifications (PTMs) constitute a significant set of PTMs that specifically target the thiol group of cysteine residues. These modifications are evident in various physiological and pathological contexts, including situations marked by oxidative stress. Redox-mediated post-translational modifications (PTMs) constitute a significant group of PTMs that specifically affect the thiol group of cysteine residues. These modifications are evident in various physiological and pathological conditions characterized by oxidative stress (Moran et al., 2001; Dalle-Donne et al., 2008; Yang et al., 2014). One prominent mechanism for redox-mediated thiol modulation is S-glutathionylation, which involves adding a glutathione (GSH) group to the protein. The presence of reactive oxygen species (ROS) plays a vital role in facilitating S-glutathionylation. This phenomenon is increasingly observed in various ion channels, including voltage-gated Ca²⁺ channels and ATP-sensitive K⁺ channels (K_ATP) (Tang et al., 2011; Yang et al., 2011).

Reduced GSH is a significant non-enzymatic antioxidant in mammalian cells (Averill-Bates, 2023). GSH is a tripeptide composed of glycine, cysteine, glutamate, and the active thiol group in the cysteine residue that acts as a potent antioxidant. This antioxidant GSH is produced within the cell’s cytoplasm and transported to the mitochondria (Wadey et al., 2009). Hydrogen sulfide (H₂S) has long been regarded as toxic, but it is now being found to play an important physiological role (at low concentrations). Nitric oxide (NO) is another well-known gaseous intracellular signal transducer, including H₂S. H₂S is produced from cysteine by several enzymes and plays a physiological role in cell signaling regulation, homeostasis, and combating oxidative species, such as ROS/RNS, in the body (Olas, 2015; Shefa et al., 2018).

Studies on the modulation of ion channel functions by NO and H₂S are summarized in Table 2.

2.2 Ion channel mutations and oxidative stress

Most known human ion channel diseases or channelopathies are hereditary and investigated through genetic approaches (Li and Lester, 2001). Genetic analysis studies can be challenging because the clinical phenotypes are complex, and significant genetic heterogeneity exists. In other words, mutations in different genes may lead to the same clinical phenotype. Despite these challenges, numerous genes associated with human diseases have been successfully identified, characterized, and localized by applying molecular genetic techniques (Li and Lester, 2001; Nam et al., 2023a). Genome-wide association studies (GWAS) have linked ion channels to oxidative stress-related disorders (Akbarali, 2014; Ramírez et al., 2016; Liguori et al., 2018). The consequences of these ion channel mutations related to oxidative stress are diverse and contribute to the pathogenesis of various diseases, such as neurological disorders, cardiac arrhythmias, and certain types of cancers. Moreover, the aging process is linked with increased oxidative stress and a higher incidence of ion channel dysfunctions (Uttara et al., 2009; Chang et al., 2014; Kurian et al., 2016; Liguori et al., 2018). Understanding the relationship between ion channel mutations and oxidative stress is essential for developing targeted therapeutic strategies. Detailed information on specific potassium channel mutations and oxidative stress-related disorders, such as ataxias, can be found in these excellent manuscripts (Figueroa et al., 2010; Duarri et al., 2012; Duarri et al., 2012; Lee et al., 2012; Nam et al., 2023a). This review will generally cover different ion channel mutations caused by oxidative stress in neurodegenerative diseases.

3 Oxidative stress in neurodegenerative disorders

Neurodegenerative disorders affect millions of people worldwide. Brain atrophy is the hallmark of neurodegenerative diseases due to constant decline in neuronal function. Despite age being a significant risk factor for all neurodegenerative disorders, recent research indicates that genetic makeup and environmental factors greatly influence the risk as well (Chen et al., 2012; Lamptey et al., 2022). Although neurodegenerative disorders have distinct etiologies and develop in different brain sites, recent studies have observed that their effects on cellular and molecular mechanisms are similar (Aborode et al., 2022; Gates et al., 2022; Teleanu et al., 2022; Rehman et al., 2023). The central nervous system (CNS) has a significant oxidative potential because of its elevated oxygen usage. However, the CNS is particularly vulnerable to oxidative stress because of the abundance of readily oxidizable substances, limited levels of primary and secondary antioxidants, elevated iron content in specific brain regions, the generation of ROS by various internal mechanisms, and the presence of non-replicating neurons (Maher, 2006; Adibhatla and Hatcher, 2010; Guevara-García et al., 2012). Figure 1 demonstrates the tendency of neurodegenerative diseases to progress as a result of oxidative stress (Teleanu et al., 2022). Cells malfunction and even undergo apoptosis because the redox balance shifts to oxidative (Lew et al., 2022). Various neurodegenerative disorders are believed to be impacted by oxidative stress (Figure 1). Ion channels’ dysregulation is another common pathophysiologic mechanism that causes degenerative CNS diseases of widely differing genetic etiologies (Huang and Shakkottai, 2023). Furthermore, H₂S at low concentrations lowers the level of ROS and thus protects neurons from oxidative stresses (Shefa et al., 2018). The inhaled form of H₂S has a neuroprotective role In a Parkinson’s disease mouse model (Kida et al., 2011). It also protects neurons from apoptosis and degeneration (Olas, 2015).

Oxidative stress has been suggested as a factor in the development of various neurodegenerative disorders, including certain types of ataxias. The etiology of the diseases is multifaceted, with genetic and familial investigations underscoring their heterogeneity (Guevara-García et al., 2012). Point mutations often lead to diminished expression of proteins specific to the mutated genes. The connection between neurodegenerative disorders and oxidative stress is dependent on molecular, in vitro, and animal studies findings. Nonetheless, conflicting results emerge from human biomarker studies, indicating the necessity for additional research on the role of redox in neurodegenerative disorders associated with channelopathies (Li and Lester, 2001; Guevara-García et al., 2012).

Listed below are some findings that correlate with the modulation of ion channels and overproduction of ROS with neurodegenerative disorders, such as inherited cerebellar ataxia and Parkinson’s disease.

3.1 Inherited cerebellar ataxia

Inherited Cerebellar Ataxias (ICAs) combine a group of complex and uncommon neurodegenerative conditions that impact the cerebellum, spinal cord, and peripheral nerves (Coarelli et al., 2023). A person with ICA can experience balance, gait, speech, limb movement, eye movement, and cognitive difficulties. A significant correlation exists between ataxia location and cerebellar neuropathology: hemisphere lesions result in limb or appendicular ataxia, while midline lesions result in gait ataxia (Kashyap et al., 2020). Spinocerebellar ataxia (SCA) is a subgroup of hereditary cerebellar ataxia, a progressive, neurodegenerative, heterogeneous, rare disease that affects the cerebellum (Brooker et al., 2021; Bhandari et al., 2023). The pathology of spinocerebellar ataxia is still unknown, but the principal cells involved in degeneration are Purkinje cells (Koeppen, 2005). Purkinje cells regulate fine movement and muscle coordination. Thus, a decline in the normal firing of the Purkinje cells leads to an excessive calcium influx and excitotoxicity (Koeppen, 2005; Hosy et al., 2011). In the CNS, particularly the cerebellum, histopathology shows atrophy and enlargement of the lateral ventricles, loss of myelin in the frontal horn of the spinal cord, and axonal degeneration (Bhandari et al., 2023).

3.1.1 ICA and oxidative stress

There is an association between oxidative stress and several neurological disorders, including hereditary ataxias (Guevara-García et al., 2012; Lew et al., 2022). Numerous investigations have been conducted to prove the therapeutic roles of antioxidants in ICAs (Sarva and Shanker, 2014; Braga Neto et al., 2016; Picher-Martel and Dupre, 2018). Nevertheless, the results indicated that these antioxidants only partially alleviated symptoms of ICAs. This limitation may be because of the emphasis on clinical outcomes rather than a comprehensive understanding of the underlying molecular mechanisms associated with their approach to addressing oxidative stress (Picher-Martel and Dupre, 2018; Lew et al., 2022). The cause of ICAs is diverse (Coarelli et al., 2023). The link between ataxia and oxidative stress depends mainly on molecular, in vitro, and in vivo studies. Recent findings, for example, have indicated that ataxin 2 and others are linked with the redox imbalance in this disease (Guevara-García et al., 2012).

The significance of understanding the influence of oxidative stress on ion channels is crucial in considering ataxias. It is also needed to develop innovative approaches via alternative therapeutic intervention in ICA and related diseases.

3.1.2 Ion channels involved in oxidative stress-related ataxia

A cerebellar cortex includes Purkinje cells that integrate all input into the cerebellum (Hosy et al., 2011; Hirano, 2018; Huang and Shakkottai, 2023). A common feature of cerebellar ataxia is cerebellar atrophy and Purkinje neuron degeneration (Koeppen, 2005; Cocozza et al., 2021). Purkinje neurons are unique in that they spike independently of synaptic stimulation. SCA mouse models demonstrate that disruptions in the firing in Purkinje neurons considerably weaken motor function, indicating that this pacemaking ability of Purkinje neurons plays a critical role in motor coordination (Kurian et al., 2016; Bhandari et al., 2023; Dell’Orco et al., 2015; Jayabal et al., 2016). In resting conditions, Purkinje neurons fire at an average frequency of 40 Hz with unvarying inter-spike interval duration. Ion channels are predominantly responsible for maintaining this regularity (Raman and Bean, 1999; Braga Neto et al., 2016; Huang and Shakkottai, 2023).

In Purkinje neurons, voltage-gated Na⁺ channels (Na_v1.6 and Na_v1.1) initiate action potentials when they are activated. Then, the voltage-gated K⁺ channel activation will mediate the repolarization of the action potential. Ca²⁺ enters Purkinje neurons via voltage-gated Ca²⁺ channels, mainly Ca_v2.1 and Ca_v3.1, upon depolarization. When Ca²⁺ binds to a specific type of K⁺ channel, called Ca²⁺-activated K⁺ channels, an outward K⁺ current is generated, and the Purkinje neuron is hyperpolarized to produce the afterhyperpolarization (AHP) (Cooper and Jan, 1999; Li and Lester, 2001; Burke and Bender, 2019). The main Ca²⁺-activated K⁺ channels that generate the AHP in Purkinje neurons are small-conductance Ca²⁺-activated K⁺ channels type 2 (K_Ca2.2) channels (Kasumu et al., 2012; Nam et al., 2017; Nam et al., 2023b) and large-conductance Ca²⁺-activated K⁺ (BK) channels (Du et al., 2020) (Table 3).

Because ion channels play an important function in Purkinje neuron physiology, maintaining redox equilibrium is crucial to maintaining neurons’ homeostasis due to the alteration of their activity by oxidative stress. Enzymatic antioxidants, such as superoxide dismutase, glutathione peroxidases, and catalase, along with non-enzymatic antioxidants like GSH and vitamins A, C, and E, counteract various types of oxidative stress (Irato and Santovito, 2021). These antioxidants, whether endogenous or exogenous, reduce oxidative stress and scavenge ROS in ICAs, which could pave the way for a new ICA treatment (Pandolfo, 2008; Lew et al., 2022). Activating antioxidative transcription factor NRF2 could be a viable strategy to alleviate oxidative damage in ICAs (Kavian et al., 2018). In response to oxidative stress, NRF2 modulates key antioxidant enzymes, which, either directly or indirectly, regulate redox homeostasis (Liu et al., 2016; Lew et al., 2022). AM-36 is a neuroprotective agent that combines antioxidant and Na⁺ channel blockade properties (Callaway et al., 2001). Compared to agents possessing only one of these actions, AM-36 inhibited toxicity and apoptosis (mediated by the generation of ROS) (Callaway et al., 2001). Therefore, it is important to understand the link between the strategy targeting specific ion channels and antioxidants in mediating the progression of ICAs.

3.2 Parkinson’s disease

Parkinson’s disease (PD) is a common neurodegenerative condition distinguished by the progressive degeneration of dopaminergic cells in the substantia nigra, a region in the midbrain known for its accumulation of synuclein (Poewe et al., 2017). The dopamine secretion by these neurons is crucial for controlling movement ease and balance. Multiple pathways and mechanisms are involved in the underlying molecular pathogenesis, including synthase proteostasis, oxidative stress, mitochondrial function, neuroinflammation, Ca²⁺ homeostasis, and axonal transport (Miraglia et al., 2015; Poewe et al., 2017). The etiologies of PD are still questionable. Leucine-rich repeat kinase 2 (LRRK2) Mutations are one of the causative genetic variants that account for several autosomal, dominantly inherited PD (Blauwendraat et al., 2020). It has also been discovered that other genes, including ATP13A2, SNCA, PINK, GIGYF2, HTRA2, and DJ1, can cause familiar and early-onset PD. Among their functions are the degradation of ubiquitin proteins, the response to oxidative stress, apoptosis, cell survival, and mitochondrial function (Maiti et al., 2017).

3.2.1 Parkinson’s diseases and oxidative stress

Oxidative stress significantly promotes the erosion of dopaminergic neurons in PD (Dias et al., 2013). Oxygen is essential for brain function, and a large amount of oxygen is converted into ROS. Overproduction of ROS in the brain raises oxidative stress in people with Parkinson’s disease (Chang and Chen, 2020). Oxidative stress is closely related to other components of the degenerative process, like excitotoxicity, nitric oxide toxicity, and mitochondrial dysfunction (Jenner, 2003; Henchcliffe and Beal, 2008). Several genes associated with familial PD, including parkin, alpha-synuclein, LRRK2, DJ-1, and PINK-1, have been identified, providing important understandings of the molecular pathways underlying the disease pathogenesis, as well as highlighting earlier mysterious mechanisms where oxidative stress plays a role in the disease (Dias et al., 2013). Examination of brain tissue in Parkinson’s disease patients reveals a reduced level of GSH compared to glutathione disulfide (GSSG) compared to healthy brain tissue (Sian et al., 1994; Pearce et al., 1997). As oxidative stress leads to programmed cell death, the mitochondrial condition of GSH has gained recognition as a significant indicator of this occurrence (Chang and Chen, 2020).

3.2.2 Ion channels involved in oxidative stress-related Parkinson’s

Targeting ion channels provides an intriguing mechanistic strategy to address the progression of PD and other neurodegenerative disorders because of their important roles in neuronal activities (Braga Neto et al., 2016). K⁺ channels are important in neuronal excitability, neurotransmitter release, neuroinflammation, and synaptic transmission in PD pathology. In dopaminergic neurons, voltage-dependent K⁺ currents mediate repolarizing action potentials and fine-tune pacemaker firing rates (Braga Neto et al., 2016; Picher-Martel and Dupre, 2018). Voltage-gated Na⁺ channels modulate pacemaker frequency (Chen et al., 2012; Sarva and Shanker, 2014).

Tetrodotoxin inhibits the voltage-gated Na⁺ channels, revealing slow oscillatory potentials regulated by L-Type voltage-gated Ca²⁺ channels that regulate the precision, frequency, and robustness of peacemaking (Zaichick et al., 2017) (Table 3). While excessive firing and excess Ca²⁺ are significantly studied in connection to neurodegeneration, the direct function of the related ion channels in PD pathogenesis is mysterious. A variety of Parkinson’s disease animal models, ranging from toxin-induced to genetically modified mice, exhibit abnormalities in the operation of different ion channels (Daniel et al., 2021). The pathogenesis of Parkinson’s disease encompasses numerous interconnected pathways, including protein aggregation, oxidative stress, mitochondrial impairments, and abnormalities in autophagy. As a result, there have been numerous efforts to address these pathways in order to provide neuroprotection (Daniel et al., 2021). While several of these drugs in preclinical studies have demonstrated positive outcomes, none of these interventions have effectively transitioned into clinical application (Jenner, 2003).

In the field of ion channel drug discovery, a significant challenge is preventing side effects arising from both target and off-target mechanisms. Additionally, subtype selectivity is challenging when various homologous members belong to the same subfamily (Brown et al., 2020; Chen et al., 2023).

4 Concluding remarks

Ion channel malfunction is a common factor in neurological disorders, even when various genes are implicated as the root causes of these diseases. The malfunction of ion channels can result from changes in the intracellular redox environment, which alter how these channels function. Consequently, oxidative stress shows a significant role in the onset and development of neurodegenerative conditions involving ataxias, Parkinson’s, Alzheimer’s, and ALS. Despite recent advancements, the precise mechanisms of reactive oxygen species (ROS)-mediated neurodegenerative diseases remain partially understood. The role of ion channels in neurodegenerative disorders associated with oxidative stress has now been recognized, as they experience functional adjustments in such conditions. However, the significance of targeting ion channels therapeutically varies depending on the disease and the tissues in which these channels are active. Ultimately, neurodegenerative diseases may be effectively treated with a combination of ion channel-modulating therapy and antioxidant medication. More research on the function of ion channels in oxidative stress may provide a platform for exploring new therapeutic approaches for treating many neurodegenerative diseases associated with oxidative stress.

References

• 1

  AborodeA. T.PustakeM.AwuahW. A.AlwerdaniM.ShahP.YarlagaddaR.et al (2022). Targeting oxidative stress mechanisms to treat alzheimer’s and Parkinson’s disease: a critical review. Oxid. Med. Cell Longev.2022, 7934442. 10.1155/2022/7934442

  • CrossRef
  • Google Scholar

• 2

  AdelmanJ. P.ClaphamD. E.HibinoH.InanobeA.JanL. Y.KarschinA.et al (2023). Inwardly rectifying potassium channels (K_IR) in GtoPdb v.2023.1. IUPHARBPS Guide Pharmacol. CITE2023. 10.2218/gtopdb/F74/2023.1

  • CrossRef
  • Google Scholar

• 3

  AdibhatlaR. M.HatcherJ. F. (2010). Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal12, 125–169. 10.1089/ars.2009.2668

  • CrossRef
  • Google Scholar

• 4

  AggarwalP.SinghS.RavichandiranV. (2021). Two-pore domain potassium channel in neurological disorders. J. Membr. Biol.254, 367–380. 10.1007/s00232-021-00189-8

  • CrossRef
  • Google Scholar

• 5

  AkbaraliH. (2014). Oxidative stress and ion channels. Syst. Biol. Free Radic. Antioxid., 355–373. 10.1007/978-3-642-30018-9_12

  • CrossRef
  • Google Scholar

• 6

  AldrichR.ChandyK. G.GrissmerS.GutmanG. A.KaczmarekL. K.WeiA. D.et al (2021). IUPHAR/BPS guide to pharmacology CITE [English]. Edinburgh University Library. Available at: http://journals.ed.ac.uk/gtopdb-cite.

  • Google Scholar

• 7

  AlmanzaA.NavarreteF.VegaR.SotoE. (2007). Modulation of voltage-gated Ca2+ current in vestibular hair cells by nitric oxide. J. Neurophysiol.97, 1188–1195. 10.1152/jn.00849.2006

  • CrossRef
  • Google Scholar

• 8

  AnnunziatoL.PannaccioneA.CataldiM.SecondoA.CastaldoP.Di RenzoG.et al (2002). Modulation of ion channels by reactive oxygen and nitrogen species: a pathophysiological role in brain aging?Neurobiol. Aging23, 819–834. 10.1016/s0197-4580(02)00069-6

  • CrossRef
  • Google Scholar

• 9

  ArtinianL.ZhongL.YangH.RehderV. (2012). Nitric oxide as intracellular modulator: internal production of NO increases neuronal excitability via modulation of several ionic conductances. Eur. J. Neurosci.36, 3333–3343. 10.1111/j.1460-9568.2012.08260.x

  • CrossRef
  • Google Scholar

• 10

  AshokA.AndrabiS. S.MansoorS.KuangY.KwonB. K.LabhasetwarV. (2022). Antioxidant therapy in oxidative stress-induced neurodegenerative diseases: role of nanoparticle-based drug delivery systems in clinical translation. Antioxidants (Basel).11 (2), 408. 10.3390/antiox11020408

  • CrossRef
  • Google Scholar

• 11

  Averill-BatesD. A. (2023). The antioxidant glutathione. Vitam. Horm.121, 109–141. 10.1016/bs.vh.2022.09.002

  • CrossRef
  • Google Scholar

• 12

  BarbieriR.NizzariM.ZanardiI.PuschM.GavazzoP. (2023). Voltage-gated sodium channel dysfunctions in neurological disorders. Life13, 1191. 10.3390/life13051191

  • CrossRef
  • Google Scholar

• 13

  BhandariJ.ThadaP. K.SamantaD. (2023). Spinocerebellar ataxia. StatPearls, treasure island (FL). St. Petersburg, Florida: StatPearls Publishing.

  • Google Scholar

• 14

  BirbenE.SahinerU. M.SackesenC.ErzurumS.KalayciO. (2012). Oxidative stress and antioxidant defense. World Allergy Organ J.5, 9–19. 10.1097/WOX.0b013e3182439613

  • CrossRef
  • Google Scholar

• 15

  BlauwendraatC.NallsM. A.SingletonA. B. (2020). The genetic architecture of Parkinson’s disease. Lancet Neurol.19, 170–178. 10.1016/S1474-4422(19)30287-X

  • CrossRef
  • Google Scholar

• 16

  BogeskiI.NiemeyerB. A. (2014). Redox regulation of ion channels. Antioxid. Redox Signal21, 859–862. 10.1089/ars.2014.6019

  • CrossRef
  • Google Scholar

• 17

  Braga NetoP.PedrosoJ. L.KuoS.-H.Marcondes JuniorC. F.TeiveH. A. G.BarsottiniO. G. P. (2016). Current concepts in the treatment of hereditary ataxias. Arq. Neuropsiquiatr.74, 244–252. 10.1590/0004-282X20160038

  • CrossRef
  • Google Scholar

• 18

  BrockM. W.MathesC.GillyW. F. (2001). Selective open-channel block of shaker (Kv1) potassium channels by S-nitrosodithiothreitol (sndtt). J. Gen. Physiol.118, 113–134. 10.1085/jgp.118.1.113

  • CrossRef
  • Google Scholar

• 19

  BrookerS. M.EdamakantiC. R.AkashaS. M.KuoS.-H.OpalP. (2021). Spinocerebellar ataxia clinical trials: opportunities and challenges. Ann. Clin. Transl. Neurol.8, 1543–1556. 10.1002/acn3.51370

  • CrossRef
  • Google Scholar

• 20

  BrownB. M.ShimH.ChristophersenP.WulffH. (2020). Pharmacology of small- and intermediate-conductance calcium-activated potassium channels. Annu. Rev. Pharmacol. Toxicol.60, 219–240. 10.1146/annurev-pharmtox-010919-023420

  • CrossRef
  • Google Scholar

• 21

  BrowneS. E.FerranteR. J.BealM. F. (1999). Oxidative stress in Huntington’s disease. Brain Pathol. Zurich Switz.9, 147–163. 10.1111/j.1750-3639.1999.tb00216.x

  • CrossRef
  • Google Scholar

• 22

  BurkeK. J.BenderK. J. (2019). Modulation of ion channels in the axon: mechanisms and function. Front. Cell Neurosci.13, 221. 10.3389/fncel.2019.00221

  • CrossRef
  • Google Scholar

• 23

  BushartD. D.ShakkottaiV. G. (2019). Ion channel dysfunction in cerebellar ataxia. Neurosci. Lett.688, 41–48. 10.1016/j.neulet.2018.02.005

  • CrossRef
  • Google Scholar

• 24

  ButtA. M.KalsiA. (2006). Inwardly rectifying potassium channels (Kir) in central nervous system glia: a special role for Kir4.1 in glial functions. J. Cell Mol. Med.10, 33–44. 10.1111/j.1582-4934.2006.tb00289.x

  • CrossRef
  • Google Scholar

• 25

  CallawayJ. K.BeartP. M.JarrottB.GiardinaS. F. (2001). Incorporation of sodium channel blocking and free radical scavenging activities into a single drug, AM-36, results in profound inhibition of neuronal apoptosis. Br. J. Pharmacol.132, 1691–1698. 10.1038/sj.bjp.0704018

  • CrossRef
  • Google Scholar

• 26

  CatterallW. A. (2011). Voltage-gated calcium channels. Cold Spring Harb. Perspect. Biol.3, a003947. 10.1101/cshperspect.a003947

  • CrossRef
  • Google Scholar

• 27

  ChangK.-H.ChenC.-M. (2020). The role of oxidative stress in Parkinson’s disease. Antioxidants9, 597. 10.3390/antiox9070597

  • CrossRef
  • Google Scholar

• 28

  ChangX.WangJ.JiangH.ShiL.XieJ. (2019). Hyperpolarization-activated cyclic nucleotide-gated channels: an emerging role in neurodegenerative diseases. Front. Mol. Neurosci.12, 141. 10.3389/fnmol.2019.00141

  • CrossRef
  • Google Scholar

• 29

  ChangY.-T.ChangW.-N.TsaiN.-W.HuangC.-C.KungC.-T.SuY.-J.et al (2014). The roles of biomarkers of oxidative stress and antioxidant in alzheimer’s disease: a systematic review. Biomed. Res. Int.2014, 182303. 10.1155/2014/182303

  • CrossRef
  • Google Scholar

• 30

  ChenJ.DaggettH.De WaardM.HeinemannS. H.HoshiT. (2002). Nitric oxide augments voltage-gated P/Q-type Ca(2+) channels constituting a putative positive feedback loop. Free Radic. Biol. Med.32, 638–649. 10.1016/s0891-5849(02)00748-7

  • CrossRef
  • Google Scholar

• 31

  ChenX.FengY.QuinnR. J.PountneyD. L.RichardsonD. R.MellickG. D.et al (2023). Potassium channels in Parkinson’s disease: potential roles in its pathogenesis and innovative molecular targets for treatment. Pharmacol. Rev.75, 758–788. 10.1124/pharmrev.122.000743

  • CrossRef
  • Google Scholar

• 32

  ChenX.GuoC.KongJ. (2012). Oxidative stress in neurodegenerative diseases. Neural Regen. Res.7, 376–385. 10.3969/j.issn.1673-5374.2012.05.009

  • CrossRef
  • Google Scholar

• 33

  CoarelliG.WirthT.TranchantC.KoenigM.DurrA.AnheimM. (2023). The inherited cerebellar ataxias: an update. J. Neurol.270, 208–222. 10.1007/s00415-022-11383-6

  • CrossRef
  • Google Scholar

• 34

  CocozzaS.PontilloG.De MicheleG.Di StasiM.GuerrieroE.PerilloT.et al (2021). Conventional MRI findings in hereditary degenerative ataxias: a pictorial review. Neuroradiology63, 983–999. 10.1007/s00234-021-02682-2

  • CrossRef
  • Google Scholar

• 35

  CooperE. C.JanL. Y. (1999). Ion channel genes and human neurological disease: recent progress, prospects, and challenges. Proc. Natl. Acad. Sci.96, 4759–4766. 10.1073/pnas.96.9.4759

  • CrossRef
  • Google Scholar

• 36

  Cunha-OliveiraT.MontezinhoL.MendesC.FiruziO.SasoL.OliveiraP. J.et al (2020). Oxidative stress in amyotrophic lateral sclerosis: pathophysiology and opportunities for pharmacological intervention. Oxid. Med. Cell Longev.2020, 5021694. 10.1155/2020/5021694

  • CrossRef
  • Google Scholar

• 37

  Dalle-DonneI.MilzaniA.GaglianoN.ColomboR.GiustariniD.RossiR. (2008). Molecular mechanisms and potential clinical significance of S-glutathionylation. Antioxid. Redox Signal10, 445–473. 10.1089/ars.2007.1716

  • CrossRef
  • Google Scholar

• 38

  DanielN. H.AravindA.ThakurP. (2021). Are ion channels potential therapeutic targets for Parkinson’s disease?NeuroToxicology87, 243–257. 10.1016/j.neuro.2021.10.008

  • CrossRef
  • Google Scholar

• 39

  D’AscenzoM.MartinottiG.AzzenaG. B.GrassiC. (2002). cGMP/protein kinase G-dependent inhibition of N-type Ca2+ channels induced by nitric oxide in human neuroblastoma IMR32 cells. J. Neurosci. Off. J. Soc. Neurosci.22, 7485–7492. 10.1523/JNEUROSCI.22-17-07485.2002

  • CrossRef
  • Google Scholar

• 40

  de Lera RuizM.KrausR. L. (2015). Voltage-gated sodium channels: structure, function, pharmacology, and clinical indications. J. Med. Chem.58, 7093–7118. 10.1021/jm501981g

  • CrossRef
  • Google Scholar

• 41

  Dell’OrcoJ. M.WassermanA. H.ChopraR.IngramM. A. C.HuY.-S.SinghV.et al (2015). Neuronal atrophy early in degenerative ataxia is a compensatory mechanism to regulate membrane excitability. J. Neurosci. Off. J. Soc. Neurosci.35, 11292–11307. 10.1523/JNEUROSCI.1357-15.2015

  • CrossRef
  • Google Scholar

• 42

  DiasV.JunnE.MouradianM. M. (2013). The role of oxidative stress in Parkinson’s disease. J. Park Dis.3, 461–491. 10.3233/JPD-130230

  • CrossRef
  • Google Scholar

• 43

  DiFrancescoJ. C.DiFrancescoD. (2015). Dysfunctional HCN ion channels in neurological diseases. Front. Cell Neurosci.6, 174. 10.3389/fncel.2015.00071

  • CrossRef
  • Google Scholar

• 44

  DuX.Carvalho-de-SouzaJ. L.WeiC.Carrasquel-UrsulaezW.LorenzoY.GonzalezN.et al (2020). Loss-of-function BK channel mutation causes impaired mitochondria and progressive cerebellar ataxia. Proc. Natl. Acad. Sci. U. S. A.117, 6023–6034. 10.1073/pnas.1920008117

  • CrossRef
  • Google Scholar

• 45

  DuarriA.JezierskaJ.FokkensM.MeijerM.SchelhaasH. J.den DunnenW. F. A.et al (2012). Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19. Ann. Neurol.72, 870–880. 10.1002/ana.23700

  • CrossRef
  • Google Scholar

• 46

  FanX.LuY.DuG.LiuJ. (2022). Advances in the understanding of two-pore domain TASK potassium channels and their potential as therapeutic targets. Molecules27, 8296. 10.3390/molecules27238296

  • CrossRef
  • Google Scholar

• 47

  FigueroaK. P.MinassianN. A.StevaninG.WatersM.GaribyanV.ForlaniS.et al (2010). KCNC3: phenotype, mutations, channel biophysics – a study of 260 familial ataxia patients. Hum. Mutat.31, 191–196. 10.1002/humu.21165

  • CrossRef
  • Google Scholar

• 48

  FogelB. L.HansonS. M.BeckerE. B. E. (2015). Do mutations in the murine ataxia gene TRPC3 cause cerebellar ataxia in humans?Mov. Disord. Off. J. Mov. Disord. Soc.30, 284–286. 10.1002/mds.26096

  • CrossRef
  • Google Scholar

• 49

  GatesE. J.BernathA. K.KlegerisA. (2022). Modifying the diet and gut microbiota to prevent and manage neurodegenerative diseases. Rev. Neurosci.33, 767–787. 10.1515/revneuro-2021-0146

  • CrossRef
  • Google Scholar

• 50

  GellaA.DuranyN. (2009). Oxidative stress in Alzheimer disease. Cell Adhes. Migr.3, 88–93. 10.4161/cam.3.1.7402

  • CrossRef
  • Google Scholar

• 51

  GriendlingK. K.CamargoL. L.RiosF. J.Alves-LopesR.MontezanoA. C.TouyzR. M. (2021). Oxidative stress and hypertension. Circ. Res.128, 993–1020. 10.1161/CIRCRESAHA.121.318063

  • CrossRef
  • Google Scholar

• 52

  Guevara-GarcíaM.Gil-del ValleL.Velásquez-PérezL.García-RodríguezJ. C. (2012). Oxidative stress as a cofactor in spinocerebellar ataxia type 2. Redox Rep. Commun. Free Radic. Res.17, 84–89. 10.1179/1351000212Y.0000000005

  • CrossRef
  • Google Scholar

• 53

  Gulcinİ. (2020). Antioxidants and antioxidant methods: an updated overview. Arch. Toxicol.94, 651–715. 10.1007/s00204-020-02689-3

  • CrossRef
  • Google Scholar

• 54

  HarrazO. F.KlugN. R.SenatoreA. J.Hill-EubanksD. C.NelsonM. T. (2022). Piezo1 is a mechanosensor channel in central nervous system capillaries. Circ. Res.130, 1531–1546. 10.1161/CIRCRESAHA.122.320827

  • CrossRef
  • Google Scholar

• 55

  HenchcliffeC.BealM. F. (2008). Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat. Clin. Pract. Neurol.4, 600–609. 10.1038/ncpneuro0924

  • CrossRef
  • Google Scholar

• 56

  HiranoT. (2018). Purkinje neurons: development, morphology, and function. Cerebellum Lond Engl.17, 699–700. 10.1007/s12311-018-0985-7

  • CrossRef
  • Google Scholar

• 57

  HosyE.PiochonC.TeulingE.RinaldoL.HanselC. (2011). SK2 channel expression and function in cerebellar Purkinje cells. J. Physiol.589, 3433–3440. 10.1113/jphysiol.2011.205823

  • CrossRef
  • Google Scholar

• 58

  HuangH.ShakkottaiV. G. (2023). Targeting ion channels and Purkinje neuron intrinsic membrane excitability as a therapeutic strategy for cerebellar ataxia. Life13, 1350. 10.3390/life13061350

  • CrossRef
  • Google Scholar

• 59

  IratoP.SantovitoG. (2021). Enzymatic and non-enzymatic molecules with antioxidant function. Antioxidants10, 579. 10.3390/antiox10040579

  • CrossRef
  • Google Scholar

• 60

  JayabalS.ChangH. H. V.CullenK. E.WattA. J. (2016). 4-aminopyridine reverses ataxia and cerebellar firing deficiency in a mouse model of spinocerebellar ataxia type 6. Sci. Rep.6, 29489. 10.1038/srep29489

  • CrossRef
  • Google Scholar

• 61

  JennerP. (2003). Oxidative stress in Parkinson’s disease. Ann. Neurol.53 (Suppl. 3), S26–S36. 10.1002/ana.10483

  • CrossRef
  • Google Scholar

• 62

  JinP.JanL. Y.JanY.-N. (2020). Mechanosensitive ion channels: structural features relevant to mechanotransduction mechanisms. Annu. Rev. Neurosci.43, 207–229. 10.1146/annurev-neuro-070918-050509

  • CrossRef
  • Google Scholar

• 63

  KashyapB.PhanD.PathiranaP. N.HorneM.PowerL.SzmulewiczD. (2020). Objective assessment of cerebellar ataxia: a comprehensive and refined approach. Sci. Rep.10, 9493. 10.1038/s41598-020-65303-7

  • CrossRef
  • Google Scholar

• 64

  KasumuA. W.HougaardC.RodeF.JacobsenT. A.SabatierJ. M.EriksenB. L.et al (2012). Selective positive modulator of calcium-activated potassium channels exerts beneficial effects in a mouse model of spinocerebellar ataxia type 2. Chem. Biol.19, 1340–1353. 10.1016/j.chembiol.2012.07.013

  • CrossRef
  • Google Scholar

• 65

  KattoorA. J.PothineniN. V. K.PalagiriD.MehtaJ. L. (2017). Oxidative stress in atherosclerosis. Curr. Atheroscler. Rep.19, 42. 10.1007/s11883-017-0678-6

  • CrossRef
  • Google Scholar

• 66

  KaushikA. S.StrathL. J.SorgeR. E. (2020). Dietary interventions for treatment of chronic pain: oxidative stress and inflammation. Pain Ther.9, 487–498. 10.1007/s40122-020-00200-5

  • CrossRef
  • Google Scholar

• 67

  KavianN.MehlalS.JeljeliM.SaiduN. E. B.NiccoC.CerlesO.et al (2018). The nrf2-antioxidant response element signaling pathway controls fibrosis and autoimmunity in scleroderma. Front. Immunol.9, 1896. 10.3389/fimmu.2018.01896

  • CrossRef
  • Google Scholar

• 68

  KawanoT.ZogaV.KimuraM.LiangM.-Y.WuH.-E.GemesG.et al (2009). Nitric oxide activates ATP-sensitive potassium channels in mammalian sensory neurons: action by direct S-nitrosylation. Mol. Pain5, 12. 10.1186/1744-8069-5-12

  • CrossRef
  • Google Scholar

• 69

  KidaK.YamadaM.TokudaK.MarutaniE.KakinohanaM.KanekiM.et al (2011). Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson’s disease. Antioxid. Redox Signal15, 343–352. 10.1089/ars.2010.3671

  • CrossRef
  • Google Scholar

• 70

  KiselyovK.MuallemS. (2016). ROS and intracellular ion channels. Cell Calcium60, 108–114. 10.1016/j.ceca.2016.03.004

  • CrossRef
  • Google Scholar

• 71

  KlockgetherT.MariottiC.PaulsonH. L. (2019). Spinocerebellar ataxia. Nat. Rev. Dis. Primer5, 24. 10.1038/s41572-019-0074-3

  • CrossRef
  • Google Scholar

• 72

  KlyachkoV. A.AhernG. P.JacksonM. B. (2001). cGMP-mediated facilitation in nerve terminals by enhancement of the spike afterhyperpolarization. Neuron31, 1015–1025. 10.1016/s0896-6273(01)00449-4

  • CrossRef
  • Google Scholar

• 73

  KoeppenA. H. (2005). The pathogenesis of spinocerebellar ataxia. Cerebellum Lond Engl.4, 62–73. 10.1080/14734220510007950

  • CrossRef
  • Google Scholar

• 74

  KurianG. A.RajagopalR.VedanthamS.RajeshM. (2016). The role of oxidative stress in myocardial ischemia and reperfusion injury and remodeling: revisited. Oxid. Med. Cell Longev.2016, 1656450. 10.1155/2016/1656450

  • CrossRef
  • Google Scholar

• 75

  KyleB. D.HurstS.SwayzeR. D.ShengJ.BraunA. P. (2013). Specific phosphorylation sites underlie the stimulation of a large conductance, Ca(2+)-activated K(+) channel by cGMP-dependent protein kinase. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol.27, 2027–2038. 10.1096/fj.12-223669

  • CrossRef
  • Google Scholar

• 76

  LamJ.ColemanN.GaringA. L. A.WulffH. (2013). The therapeutic potential of small-conductance KCa2 channels in neurodegenerative and psychiatric diseases. Expert Opin. Ther. Targets17, 1203–1220. 10.1517/14728222.2013.823161

  • CrossRef
  • Google Scholar

• 77

  LampteyR. N. L.ChaulagainB.TrivediR.GothwalA.LayekB.SinghJ. (2022). A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics. Int. J. Mol. Sci.23, 1851. 10.3390/ijms23031851

  • CrossRef
  • Google Scholar

• 78

  LeeK.JoY. Y.ChungG.JungJ. H.KimY. H.ParkC.-K. (2021). Functional importance of transient receptor potential (TRP) channels in neurological disorders. Front. Cell Dev. Biol.9, 611773. 10.3389/fcell.2021.611773

  • CrossRef
  • Google Scholar

• 79

  LeeY.DurrA.MajczenkoK.HuangY.LiuY.LienC.et al (2012). Mutations in KCND3 cause spinocerebellar ataxia type 22. Ann. Neurol.72, 859–869. 10.1002/ana.23701

  • CrossRef
  • Google Scholar

• 80

  LewS. Y.PhangM. W. L.ChongP. S.RoyJ.PoonC. H.YuW. S.et al (2022). Discovery of therapeutics targeting oxidative stress in autosomal recessive cerebellar ataxia: a systematic review. Pharmaceuticals15, 764. 10.3390/ph15060764

  • CrossRef
  • Google Scholar

• 81

  LiM.LesterH. A. (2001). Ion Channel diseases of the central nervous system. CNS Drug Rev.7, 214–240. 10.1111/j.1527-3458.2001.tb00196.x

  • CrossRef
  • Google Scholar

• 82

  LiS.WongA. H. C.LiuF. (2014). Ligand-gated ion channel interacting proteins and their role in neuroprotection. Front. Cell Neurosci.8, 125. 10.3389/fncel.2014.00125

  • CrossRef
  • Google Scholar

• 83

  LiguoriI.RussoG.CurcioF.BulliG.AranL.Della-MorteD.et al (2018). Oxidative stress, aging, and diseases. Clin. Interv. Aging13, 757–772. 10.2147/CIA.S158513

  • CrossRef
  • Google Scholar

• 84

  LitalienC.BeaulieuP. (2011). “Chapter 117 - molecular mechanisms of drug actions: from receptors to effectors,” in Pediatr. Crit. Care Editors FuhrmanB. P.ZimmermanJ. J.Fourth Ed (Saint Louis: Mosby), 1553–1568. 10.1016/B978-0-323-07307-3.10117-X

  • CrossRef
  • Google Scholar

• 85

  LiuN.BaiL.LuZ.GuR.ZhaoD.YanF.et al (2022). TRPV4 contributes to ER stress and inflammation: implications for Parkinson’s disease. J. Neuroinflammation19, 26. 10.1186/s12974-022-02382-5

  • CrossRef
  • Google Scholar

• 86

  LiuX.WardK.XavierC.JannJ.ClarkA. F.PangI.-H.et al (2016). The novel triterpenoid RTA 408 protects human retinal pigment epithelial cells against H2O2-induced cell injury via NF-E2-related factor 2 (Nrf2) activation. Redox Biol.8, 98–109. 10.1016/j.redox.2015.12.005

  • CrossRef
  • Google Scholar

• 87

  MaherP. (2006). Redox control of neural function: background, mechanisms, and significance. Antioxid. Redox Signal8, 1941–1970. 10.1089/ars.2006.8.1941

  • CrossRef
  • Google Scholar

• 88

  MaitiP.MannaJ.DunbarG. L. (2017). Current understanding of the molecular mechanisms in Parkinson’s disease: targets for potential treatments. Transl. Neurodegener.6 (28), 28. 10.1186/s40035-017-0099-z

  • CrossRef
  • Google Scholar

• 89

  MannaP.JainS. K. (2015). Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: causes and therapeutic strategies. Metab. Syndr. Relat. Disord.13, 423–444. 10.1089/met.2015.0095

  • CrossRef
  • Google Scholar

• 90

  MartinacB. (2012). Mechanosensitive ion channels: an evolutionary and scientific tour de force in mechanobiology. Channels6, 211–213. 10.4161/chan.22047

  • CrossRef
  • Google Scholar

• 91

  MiragliaF.BettiL.PalegoL.GiannacciniG. (2015). Parkinson’s disease and alpha-synucleinopathies: from arising pathways to therapeutic challenge. Cent. Nerv. Syst. Agents Med. Chem.15, 109–116. 10.2174/1871524915666150421114338

  • CrossRef
  • Google Scholar

• 92

  MirandaM. R.VestutoV.MoltedoO.ManfraM.CampigliaP.PepeG. (2023). The ion channels involved in oxidative stress-related gastrointestinal diseases. Oxygen3, 336–365. 10.3390/oxygen3030022

  • CrossRef
  • Google Scholar

• 93

  MoranL. K.GutteridgeJ. M.QuinlanG. J. (2001). Thiols in cellular redox signalling and control. Curr. Med. Chem.8, 763–772. 10.2174/0929867013372904

  • CrossRef
  • Google Scholar

• 94

  MorinoH.MatsudaY.MugurumaK.MiyamotoR.OhsawaR.OhtakeT.et al (2015). A mutation in the low voltage-gated calcium channel CACNA1G alters the physiological properties of the channel, causing spinocerebellar ataxia. Mol. Brain8, 89. 10.1186/s13041-015-0180-4

  • CrossRef
  • Google Scholar

• 95

  NamY.-W.DowneyM.RahmanM. A.CuiM.ZhangM. (2023a). Channelopathy of small- and intermediate-conductance Ca2+-activated K+ channels. Acta Pharmacol. Sin.44, 259–267. 10.1038/s41401-022-00935-1

  • CrossRef
  • Google Scholar

• 96

  NamY.-W.OrfaliR.LiuT.YuK.CuiM.WulffH.et al (2017). Structural insights into the potency of SK channel positive modulators. Sci. Rep.7, 17178. 10.1038/s41598-017-16607-8

  • CrossRef
  • Google Scholar

• 97

  NamY.-W.RahmanM. A.YangG.OrfaliR.CuiM.ZhangM. (2023b). Loss-of-function KCa2.2 mutations abolish channel activity. Am. J. Physiol-Cell Physiol.324, C658–C664. 10.1152/ajpcell.00584.2022

  • CrossRef
  • Google Scholar

• 98

  NúñezL.VaqueroM.GómezR.CaballeroR.Mateos-CáceresP.MacayaC.et al (2006). Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism. Cardiovasc Res.72, 80–89. 10.1016/j.cardiores.2006.06.021

  • CrossRef
  • Google Scholar

• 99

  OlasB. (2015). Hydrogen sulfide in signaling pathways. Clin. Chim. Acta Int. J. Clin. Chem.439, 212–218. 10.1016/j.cca.2014.10.037

  • CrossRef
  • Google Scholar

• 100

  OrfaliR.AlbanyanN. (2023). Ca2+-Sensitive potassium channels. Molecules28, 885. 10.3390/molecules28020885

  • CrossRef
  • Google Scholar

• 101

  OrfaliR.AlFaizA.RahmanM. A.LauL.NamY.-W.ZhangM. (2023). KCa2 and KCa3.1 channels in the airways: a new therapeutic target. Biomedicines11, 1780. 10.3390/biomedicines11071780

  • CrossRef
  • Google Scholar

• 102

  OrzechowskiA.CywińskaA.RostagnoA. A.RizziF. M. (2019). Oxidative stress, chronic inflammation, and amyloidoses. Oxid. Med. Cell Longev.2019, e6024975. 10.1155/2019/6024975

  • CrossRef
  • Google Scholar

• 103

  PaganL. U.GomesM. J.MartinezP. F.OkoshiM. P. (2022). Oxidative stress and heart failure: mechanisms, signalling pathways, and therapeutics. Oxid. Med. Cell Longev.2022, e9829505. 10.1155/2022/9829505

  • CrossRef
  • Google Scholar

• 104

  PandolfoM. (2008). Drug Insight: antioxidant therapy in inherited ataxias. Nat. Clin. Pract. Neurol.4, 86–96. 10.1038/ncpneuro0704

  • CrossRef
  • Google Scholar

• 105

  PearceR. K.OwenA.DanielS.JennerP.MarsdenC. D. (1997). Alterations in the distribution of glutathione in the substantia nigra in Parkinson’s disease. J. Neural Transm. (Vienna).104 (6-7), 661–677. 10.1007/BF01291884

  • CrossRef
  • Google Scholar

• 106

  Picher-MartelV.DupreN. (2018). Current and promising therapies in autosomal recessive ataxias. CNS Neurol. Disord. Drug Targets17, 161–171. 10.2174/1871527317666180419115029

  • CrossRef
  • Google Scholar

• 107

  PoeweW.SeppiK.TannerC. M.HallidayG. M.BrundinP.VolkmannJ.et al (2017). Parkinson disease. Nat. Rev. Dis. Primer3, 17013. 10.1038/nrdp.2017.13

  • CrossRef
  • Google Scholar

• 108

  PurvesD.AugustineG. J.FitzpatrickD.KatzL. C.LaMantiaA.-S.McNamaraJ. O.et al (2001a). “Voltage-gated ion channels,” in Neurosci. 2nd Ed. (Sunderland, Massachusetts: Sinauer Associates).

  • Google Scholar

• 109

  PurvesD.AugustineG. J.FitzpatrickD.KatzL. C.LaMantiaA.-S.McNamaraJ. O.et al (2001b). “Ligand-gated ion channels,” in Neurosci. 2nd Ed. (Sunderland, Massachusetts: Sinauer Associates).

  • Google Scholar

• 110

  RahmanM. A.OrfaliR.DaveN.LamE.NaguibN.NamY.-W.et al (2023). KCa2.2 (KCNN2): a physiologically and therapeutically important potassium channel. J. Neurosci. Res.101, 1699–1710. 10.1002/jnr.25233

  • CrossRef
  • Google Scholar

• 111

  RamanI. M.BeanB. P. (1999). Ionic currents underlying spontaneous action potentials in isolated cerebellar Purkinje neurons. J. Neurosci. Off. J. Soc. Neurosci.19, 1663–1674. 10.1523/JNEUROSCI.19-05-01663.1999

  • CrossRef
  • Google Scholar

• 112

  RamírezA.Vázquez-SánchezA. Y.Carrión-RobalinoN.CamachoJ. (2016). Ion channels and oxidative stress as a potential link for the diagnosis or treatment of liver diseases. Oxid. Med. Cell Longev.2016, 3928714. 10.1155/2016/3928714

  • CrossRef
  • Google Scholar

• 113

  RatherM. A.KhanA.WangL.JahanS.RehmanM. U.MakeenH. A.et al (2023). TRP channels: role in neurodegenerative diseases and therapeutic targets. Heliyon9, e16910. 10.1016/j.heliyon.2023.e16910

  • CrossRef
  • Google Scholar

• 114

  RehmanM. U.SeharN.DarN. J.KhanA.ArafahA.RashidS.et al (2023). Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: an update on current advances and impediments. Neurosci. Biobehav Rev.144, 104961. 10.1016/j.neubiorev.2022.104961

  • CrossRef
  • Google Scholar

• 115

  RinkeI.ArtmannJ.SteinV. (2010). ClC-2 voltage-gated channels constitute part of the background conductance and assist chloride extrusion. J. Neurosci.30, 4776–4786. 10.1523/JNEUROSCI.6299-09.2010

  • CrossRef
  • Google Scholar

• 116

  RiverónF. G.MartínezB. O.GutiérrezG. R.PandolfiB. A.PupoB. J.PereiraN.et al (2010). Oxidative damage and antioxidant enzymes in blood of patients with Spinocerebellar Ataxia Type 2. Rev. Cuba Gen.4 (1), 42–47.

  • Google Scholar

• 117

  Rosendo-PinedaM. J.MorenoC. M.VacaL. (2020). Role of ion channels during cell division. Cell Calcium91, 102258. 10.1016/j.ceca.2020.102258

  • CrossRef
  • Google Scholar

• 118

  SantulliG.NakashimaR.YuanQ.MarksA. R. (2017). Intracellular calcium release channels: an update. J. Physiol.595, 3041–3051. 10.1113/JP272781

  • CrossRef
  • Google Scholar

• 119

  SarvaH.ShankerV. L. (2014). Treatment options in degenerative cerebellar ataxia: a systematic review. Mov. Disord. Clin. Pract.1, 291–298. 10.1002/mdc3.12057

  • CrossRef
  • Google Scholar

• 120

  SaundersA.HuangK. W.SabatiniB. L. (2016). Globus pallidus externus neurons expressing parvalbumin interconnect the subthalamic nucleus and striatal interneurons. PloS One11, e0149798. 10.1371/journal.pone.0149798

  • CrossRef
  • Google Scholar

• 121

  SawamuraS.ShirakawaH.NakagawaT.MoriY.KanekoS. (2017). “TRP channels in the brain: what are they there for?,” in Neurobiol. TRP channels. Editor EmirT. L. R. (Boca Raton (FL): CRC Press/Taylor and Francis).

  • Google Scholar

• 122

  SchampelA.KuertenS. (2017). Danger: high voltage—the role of voltage-gated calcium channels in central nervous system pathology. Cells6, 43. 10.3390/cells6040043

  • CrossRef
  • Google Scholar

• 123

  ScheiblichH.SteinertJ. R. (2021). Nitrergic modulation of neuronal excitability in the mouse hippocampus is mediated via regulation of Kv2 and voltage-gated sodium channels. Hippocampus31, 1020–1038. 10.1002/hipo.23366

  • CrossRef
  • Google Scholar

• 124

  SelivanovV. A.VotyakovaT. V.PivtoraikoV. N.ZeakJ.SukhomlinT.TruccoM.et al (2011). Reactive oxygen species production by forward and reverse electron fluxes in the mitochondrial respiratory chain. PLOS Comput. Biol.7, e1001115. 10.1371/journal.pcbi.1001115

  • CrossRef
  • Google Scholar

• 125

  ShahM. M. (2014). Cortical HCN channels: function, trafficking and plasticity. J. Physiol.592, 2711–2719. 10.1113/jphysiol.2013.270058

  • CrossRef
  • Google Scholar

• 126

  ShahN. H.AizenmanE. (2014). Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration. Transl. Stroke Res.5, 38–58. 10.1007/s12975-013-0297-7

  • CrossRef
  • Google Scholar

• 127

  ShefaU.KimM.-S.JeongN. Y.JungJ. (2018). Antioxidant and cell-signaling functions of hydrogen sulfide in the central nervous system. Oxid. Med. Cell Longev.2018, 1873962. 10.1155/2018/1873962

  • CrossRef
  • Google Scholar

• 128

  ShenK.-F.YangX.-L.LiuG.-L.ZhuG.WangZ.-K.ShiX.-J.et al (2021). The role of voltage-gated chloride channels in the epileptogenesis of temporal lobe epilepsy. eBioMedicine70, 103537. 10.1016/j.ebiom.2021.103537

  • CrossRef
  • Google Scholar

• 129

  SianJ.DexterD. T.LeesA. J.DanielS.AgidY.Javoy-AgidF.et al (1994). Alterations in glutathione levels in Parkinson’s disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol.36, 348–355. 10.1002/ana.410360305

  • CrossRef
  • Google Scholar

• 130

  SiesH.BerndtC.JonesD. P. (2017). Oxidative stress. Annu. Rev. Biochem.86, 715–748. 10.1146/annurev-biochem-061516-045037

  • CrossRef
  • Google Scholar

• 131

  SimonF.VarelaD.Cabello-VerrugioC. (2013). Oxidative stress-modulated TRPM ion channels in cell dysfunction and pathological conditions in humans. Cell Signal25, 1614–1624. 10.1016/j.cellsig.2013.03.023

  • CrossRef
  • Google Scholar

• 132

  SpiersJ. G.SteinertJ. R. (2021). Nitrergic modulation of ion channel function in regulating neuronal excitability. Channels15, 666–679. 10.1080/19336950.2021.2002594

  • CrossRef
  • Google Scholar

• 133

  StaischJ.DuX.Carvalho-de-SouzaJ.KubotaT.BezanillaF.GomezC. (2016). A mutation causing reduced BK channel activity leads to cognitive inpairment and progressive cerebellar ataxia (P5.394). Neurology86, 86. 10.1212/wnl.86.16_supplement.p5.394

  • CrossRef
  • Google Scholar

• 134

  TabataY.ImaizumiY.SugawaraM.Andoh-NodaT.BannoS.ChaiM.et al (2018). T-Type calcium channels determine the vulnerability of dopaminergic neurons to mitochondrial stress in familial Parkinson disease. Stem Cell Rep.11, 1171–1184. 10.1016/j.stemcr.2018.09.006

  • CrossRef
  • Google Scholar

• 135

  TangG.WuL.WangR. (2010). Interaction of hydrogen sulfide with ion channels. Clin. Exp. Pharmacol. Physiol.37, 753–763. 10.1111/j.1440-1681.2010.05351.x

  • CrossRef
  • Google Scholar

• 136

  TangH.ViolaH. M.FilipovskaA.HoolL. C. (2011). Ca(v)1.2 calcium channel is glutathionylated during oxidative stress in Guinea pig and ischemic human heart. Free Radic. Biol. Med.51, 1501–1511. 10.1016/j.freeradbiomed.2011.07.005

  • CrossRef
  • Google Scholar

• 137

  TeleanuD. M.NiculescuA.-G.LunguIIRaduC. I.VladâcencoO.RozaE.et al (2022). An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases. Int. J. Mol. Sci.23, 5938. 10.3390/ijms23115938

  • CrossRef
  • Google Scholar

• 138

  UttaraB.SinghA. V.ZamboniP.MahajanR. T. (2009). Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol.7, 65–74. 10.2174/157015909787602823

  • CrossRef
  • Google Scholar

• 139

  VaidyaB.SharmaS. S. (2020). Transient receptor potential channels as an emerging target for the treatment of Parkinson’s disease: an insight into role of pharmacological interventions. Front. Cell Dev. Biol.8, 584513. 10.3389/fcell.2020.584513

  • CrossRef
  • Google Scholar

• 140

  ValkoM.RhodesC. J.MoncolJ.IzakovicM.MazurM. (2006). Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact.160, 1–40. 10.1016/j.cbi.2005.12.009

  • CrossRef
  • Google Scholar

• 141

  WadeyA. L.MuydermanH.KwekP. T.SimsN. R. (2009). Mitochondrial glutathione uptake: characterization in isolated brain mitochondria and astrocytes in culture. J. Neurochem.109 (Suppl. 1), 101–108. 10.1111/j.1471-4159.2009.05936.x

  • CrossRef
  • Google Scholar

• 142

  WangJ.OuS.-W.WangY.-J. (2017). Distribution and function of voltage-gated sodium channels in the nervous system. Channels Austin Tex11, 534–554. 10.1080/19336950.2017.1380758

  • CrossRef
  • Google Scholar

• 143

  WangR.TuS.ZhangJ.ShaoA. (2020). Roles of TRP channels in neurological diseases. Oxid. Med. Cell Longev.2020, 7289194. 10.1155/2020/7289194

  • CrossRef
  • Google Scholar

• 144

  WangZ.LinY.LiuW.KuangP.LaoW.JiY.et al (2019). Voltage-gated sodium channels are involved in cognitive impairments in Parkinson’s disease-like rats. Neuroscience418, 231–243. 10.1016/j.neuroscience.2019.08.024

  • CrossRef
  • Google Scholar

• 145

  WeaverA. K.BombenV. C.SontheimerH. (2006). Expression and function of calcium-activated potassium channels in human glioma cells. Glia54, 223–233. 10.1002/glia.20364

  • CrossRef
  • Google Scholar

• 146

  YangY.JinX.JiangC. (2014). S-glutathionylation of ion channels: insights into the regulation of channel functions, thiol modification crosstalk, and mechanosensing. Antioxid. Redox Signal20, 937–951. 10.1089/ars.2013.5483

  • CrossRef
  • Google Scholar

• 147

  YangY.ShiW.ChenX.CuiN.KonduruA. S.ShiY.et al (2011). Molecular basis and structural insight of vascular K(ATP) channel gating by S-glutathionylation. J. Biol. Chem.286, 9298–9307. 10.1074/jbc.M110.195123

  • CrossRef
  • Google Scholar

• 148

  ZaichickS. V.McGrathK. M.CaraveoG. (2017). The role of Ca2+ signaling in Parkinson’s disease. Dis. Model Mech.10, 519–535. 10.1242/dmm.028738

  • CrossRef
  • Google Scholar

• 149

  ZhangY.KaczmarekL. K. (2016). Kv3.3 potassium channels and spinocerebellar ataxia. J. Physiol.594, 4677–4684. 10.1113/JP271343

  • CrossRef
  • Google Scholar

• 150

  ZhengJ.TrudeauM. C. (2023). Textbook of ion channels volume II: properties, function, and pharmacology of the superfamilies. Boca Raton, Florida: CRC Press.

  • Google Scholar

• 151

  ZhuchenkoO.BaileyJ.BonnenP.AshizawaT.StocktonD. W.AmosC.et al (1997). Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat. Genet.15, 62–69. 10.1038/ng0197-62

  • CrossRef
  • Google Scholar